Vyepti (Eptinezumab-jjmr) for Migraine | MyMigraineTeam

Connect with others who understand.

sign up log in
About MyMigraineTeam
Powered By

Vyepti is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as preventative treatment for migraine in adults. Vyepti is also referred to by its drug name, eptinezumab-jjmr.

Vyepti is a biologic drug and a type of monoclonal antibody called a calcitonin gene-related peptide (CGRP) antagonist. It works by blocking CGRP, which is a protein that can cause migraine headaches.

How do I take it?
Prescribing information states that Vyepti is administered by intravenous (IV) infusion every three months.

Side effects
The FDA-approved label for Vyepti lists common side effects including scratchy throat, stuffy nose, and allergic reactions including skin changes like a rash. Most allergic or hypersensitivity reactions were not serious. Some serious allergic reactions may occur in people taking Vyepti, including swelling of the skin.

For more details about this treatment, visit:

Vyepti — Lundbeck

Eptinezumab-jjmr Injection — Medline Plus

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of Use and Privacy Policy.
Already a Member? Log in